Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002187 · ClinicalTrials.gov registry record · NA
A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis
A NA study, sponsored by Ionis Pharmaceuticals.
- Completed
- Registry status
- NA
- Development phase
NCT00002187 is a NA study that has completed, run by Ionis Pharmaceuticals.
The verdict
NCT00002187, a NA study, has completed, sponsored by Ionis Pharmaceuticals.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
The purpose of this study is to compare the safety and effectiveness of two dosage schedules for ISIS 2922 in the treatment of advanced cytomegalovirus (CMV) retinitis
Interventions
- DRUG Fomivirsen sodium
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002187
The ClinicalTrials.gov registry entry for NCT00002187 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Ionis Pharmaceuticals, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fomivirsen sodium is the first listed.
NCT00002187 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002187 about?
NCT00002187 is a clinical study titled "A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis". The purpose of this study is to compare the safety and effectiveness of two dosage schedules for ISIS 2922 in the treatment of advanced cytomegalovirus (CMV) retinitis
What is the current status of trial NCT00002187?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002187?
The interventions under investigation include: Fomivirsen sodium (DRUG).
Who is sponsoring clinical trial NCT00002187?
This trial is sponsored by Ionis Pharmaceuticals, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.